Champix 0.5 mg film-coated tablets

Spain
Brand name Champix 0.5 mg film-coated tablets
Form tablets, film-coated
Active substance / Dosage
VARENICLINE · 0,5 mg
Prescription type Prescription Only Medicine
Registration number 06360001
Champix 0.5 mg film-coated tablets tablets, film-coated

Package leaflet: Information for the user

Introduction

Package leaflet: information for the user

CHAMPIX 0.5 mg film-coated tablets

CHAMPIX 1 mg film-coated tablets

varenicline

Read the entire leaflet carefully before you start taking this medicine, because it contains important information for you.

  • Keep this leaflet, as you may need to read it again.
  • If you have any questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only, and you should not give it to others, even if they have the same symptoms as you, because it could harm them.
  • If you experience any adverse effects, consult your doctor or pharmacist, even if they are adverse effects not listed in this leaflet. See section 4.

Leaflet contents:

  1. What CHAMPIX is and what it is used for

  2. What you need to know before taking CHAMPIX

  3. How to take CHAMPIX

  4. Possible adverse effects

    1. Storage of CHAMPIX
  5. Contents of the pack and other information

1. What CHAMPIX is and what it is used for

CHAMPIX contains the active substance varenicline. CHAMPIX is a medicine used in adults to help them stop smoking.

CHAMPIX can help relieve the urge to smoke and withdrawal symptoms associated with quitting smoking.

CHAMPIX may also reduce the pleasure derived from smoking cigarettes if you smoke while on treatment.

2. What you need to know before taking CHAMPIX

Do not take CHAMPIX

  • If you are allergic to varenicline or to any of the other ingredients of this medicine (listed in section 6).

Warnings and precautions

Talk to your doctor or pharmacist before starting to take CHAMPIX.

Cases of depression, suicidal ideation and behavior, and suicide attempts have been reported in patients receiving CHAMPIX. If you are taking CHAMPIX and experience agitation, depressed mood, behavioral changes that concern you or your family, or develop suicidal thoughts or behavior, you must stop taking CHAMPIX and contact your doctor immediately for treatment evaluation.

Effects of quitting smoking

Changes in your body resulting from quitting smoking, with or without treatment with CHAMPIX, may alter the action of other medicines. Therefore, in some cases, a dose adjustment may be necessary. See further details below under “Other medicines and CHAMPIX”.

Quitting smoking, with or without treatment, has been associated in some individuals with an increased risk of changes in thinking or behavior, feelings of depression and anxiety, and may be associated with worsening of a psychiatric disorder. If you have a history of psychiatric disorder, discuss this with your doctor.

Cardiac symptoms

Worsening or new onset of heart or blood vessel (cardiovascular) problems has been reported, primarily in individuals who already had cardiovascular disease. Inform your doctor if you experience any change in symptoms during treatment with CHAMPIX. If you experience symptoms of a heart attack or stroke, seek emergency medical help immediately.

Seizures

Before starting treatment with CHAMPIX, inform your doctor if you have had seizures or have epilepsy. Some people have experienced seizures during treatment with CHAMPIX.

Hypersensitivity reactions

Stop taking CHAMPIX and inform your doctor immediately if you experience any of the following signs and symptoms that may indicate a severe allergic reaction: swelling of the face, lips, tongue, gums, throat or body, or difficulty breathing, wheezing.

Skin reactions

Cases of potentially life-threatening skin rash (Stevens-Johnson syndrome and erythema multiforme) have been reported with the use of CHAMPIX. If you develop a rash, blisters, or skin peeling, you must stop taking CHAMPIX and seek urgent medical attention.

Children and adolescents

CHAMPIX is not recommended for use in pediatric patients, as efficacy has not been demonstrated.

Taking CHAMPIX with other medicines

Inform your doctor or pharmacist if you are taking, have recently taken, or might need to take any other medicines.

In some cases, as a result of quitting smoking, with or without CHAMPIX, a dose adjustment of other medicines may be required. Examples include theophylline (a medicine used to treat respiratory problems), warfarin (a medicine to reduce blood clotting), and insulin (a medicine used to treat diabetes). If you have any doubts, consult your doctor or pharmacist.

If you have severe renal impairment, you should avoid taking cimetidine (a medicine for gastric problems) at the same time as CHAMPIX, as this may lead to increased blood levels of CHAMPIX.

Use of CHAMPIX with other smoking cessation therapies

Consult your doctor before using CHAMPIX in combination with other smoking cessation therapies.

Taking CHAMPIX with food and drink

There have been some reports of increased intoxicating effects of alcohol in patients taking CHAMPIX. However, it is not known whether CHAMPIX increases the effects of alcohol.

Pregnancy and breastfeeding

If you are pregnant or breastfeeding, think you may be pregnant, or are planning to become pregnant, consult your doctor or pharmacist before using this medicine.

It is preferable to avoid using CHAMPIX during pregnancy. Consult your doctor if you are planning to become pregnant.

Although not studied, CHAMPIX may pass into human breast milk. You should consult your doctor or pharmacist before taking CHAMPIX.

Driving and using machines

CHAMPIX may be associated with dizziness, drowsiness, and transient loss of consciousness. You should not drive, operate complex machinery, or engage in any other potentially hazardous activities until you know how this medicine affects your ability to perform such tasks.

CHAMPIX contains sodium

This medicine contains less than 1 mmol of sodium (23 mg) per tablet, i.e., essentially “sodium-free”.

3. How to take CHAMPIX

Follow exactly the instructions for using this medicine as given by your doctor. If you are unsure, consult your doctor or pharmacist again.

You are more likely to stop smoking if you are motivated to do so. Your doctor or pharmacist can provide you with advice, support, and additional information to help ensure your attempt to quit smoking is successful.

Normally, before starting your treatment with CHAMPIX, you should choose a quit date during the second week of treatment (between day 8 and day 14). If you do not wish or are unable to set a quit date within these 2 weeks, you may choose your quit date within the following 5 weeks after starting treatment. You should write this date on the pack as a reminder.

CHAMPIX is available as white tablets (0.5 mg) and light blue tablets (1 mg). You will start with the white tablets and normally progress to the light blue ones. See the table below for the usual dosing instructions to follow from Day 1.

Week 1

Dosage

Day 1 - 3

From day 1 to day 3, take one white film-coated tablet of CHAMPIX 0.5 mg once daily.

Day 4 - 7

From day 4 to day 7, take one white film-coated tablet of CHAMPIX 0.5 mg twice daily, once in the morning and once in the afternoon, approximately at the same time each day.

Week 2

Days 8–14

From day 8 to day 14, take one light blue film-coated tablet of CHAMPIX 1 mg twice daily, once in the morning and once in the afternoon, approximately at the same time each day.

Weeks 3 - 12

Day 15 -

End of treatment

From day 15 until the end of treatment, you should take one light blue film-coated tablet of CHAMPIX 1 mg twice daily, once in the morning and once in the evening, at approximately the same time each day.

If you have successfully stopped smoking after 12 weeks of treatment, your doctor may recommend an additional 12 weeks of treatment with CHAMPIX 1 mg film-coated tablets twice daily to help you remain abstinent.

If you are unable or unwilling to stop smoking immediately, you should reduce your tobacco consumption during the first 12 weeks of treatment and stop smoking completely by the end of this treatment period. You should then continue taking CHAMPIX 1 mg film-coated tablets twice daily for another 12 weeks, making a total of 24 weeks of treatment.

If you experience adverse effects that you cannot tolerate, your doctor may decide to temporarily or permanently reduce your dose to 0.5 mg twice daily.

If you have kidney problems, you should consult your doctor before taking CHAMPIX. You may require a lower dose.

CHAMPIX is administered orally.

The tablets should be swallowed whole with water and may be taken with or without food.

If you take more CHAMPIX than you should

If you have accidentally taken more CHAMPIX than prescribed by your doctor, contact your doctor immediately or go to the nearest hospital. Take your tablet pack with you.

If you forget to take CHAMPIX

Do not take a double dose to make up for a missed dose. It is important to take CHAMPIX regularly at the same time each day. If you miss a dose, take it as soon as possible. However, if there are 3 to 4 hours until your next scheduled dose, do not take the missed tablet.

If you stop taking CHAMPIX

Clinical trials have shown that taking all doses of your medication at the correct times and for the recommended duration, as described above, increases your chances of successfully quitting smoking. Therefore, unless your doctor instructs otherwise, it is important to continue taking CHAMPIX as directed in the table above.

In smoking cessation therapy, the risk of relapse may be high in the period immediately following the end of treatment. Temporarily, after stopping CHAMPIX, you may experience increased irritability, craving for cigarettes, depression, and/or sleep disturbances. Your doctor may decide to gradually reduce your CHAMPIX dose at the end of treatment.

If you have any further questions about the use of this medicine, ask your doctor or pharmacist.

4. Possible adverse effects

Like all medicines, this medicine can cause adverse effects, although not everyone will experience them.

Stopping smoking, with or without treatment, may produce various symptoms, which may include mood changes (such as feeling depressed, irritable, frustrated, or anxious), insomnia, difficulty concentrating, slowed heart rate, and increased appetite or weight gain.

You should be aware of the possible occurrence of serious neuropsychiatric symptoms such as agitation, depressed mood, or changes in behaviour during an attempt to quit smoking with or without CHAMPIX, and you should contact a doctor or pharmacist if you experience these symptoms.

Serious adverse effects have occurred infrequently or rarely in people trying to quit smoking with CHAMPIX: seizures, stroke, heart attack, suicidal thoughts, loss of contact with reality, and inability to think or judge clearly (psychosis), changes in thinking or behaviour (such as aggressive or abnormal behaviour), sleepwalking, diabetes, and high blood sugar levels. Serious skin reactions have also been reported, including erythema multiforme (a type of rash) and Stevens-Johnson syndrome (a serious illness with blisters on the skin, mouth, and around the eyes and genitals), as well as serious allergic reactions including angioedema (swelling of the face, mouth, or throat).

  • Very common adverse effects: may affect more than 1 in 10 people:

  • Inflammation of the nose and throat, abnormal dreams, difficulty sleeping, headache

  • Nausea

  • Common adverse effects: may affect up to 1 in 10 people:

  • Chest infection, inflammation of the sinuses

  • Weight gain, decreased appetite, increased appetite

  • Sleepiness, dizziness, changes in taste sensation

  • Difficulty breathing, cough

  • Heartburn, vomiting, constipation, diarrhoea, bloated feeling, abdominal pain, toothache, indigestion, flatulence, dry mouth

  • Skin rash, itching

  • Joint pain, myalgia, back pain

  • Chest pain, fatigue

  • Uncommon adverse effects: may affect up to 1 in 100 people:

  • Fungal infection, viral infection

  • Panic sensation, difficulty thinking, restlessness, mood changes, depression, anxiety, hallucinations, changes in sexual drive

  • Seizures, tremor, feeling of lethargy, reduced sensitivity to touch

  • Conjunctivitis, eye pain

  • Ringing in the ears

  • Angina, rapid heart rate, palpitations, increased heart rate

  • Increased blood pressure, hot flushes

  • Inflammation of the nose, sinuses, and throat, nasal, throat, and chest congestion, hoarseness, hay fever, sore throat, congested sinuses, excess nasal mucus with cough, rhinorrhoea

  • Red blood in stools, irritated stomach, change in bowel habit, belching, mouth ulcers, gum pain

  • Redness of the skin, acne, increased sweating, night sweats

  • Muscle spasms, chest wall pain

  • Abnormally frequent urination, nocturnal urination

  • Increased menstrual flow

  • Chest discomfort, flu-like illness, fever, feeling of weakness or malaise

  • High blood sugar levels

  • Heart attack

  • Suicidal thoughts

  • Changes in thinking or behaviour (such as aggression)

  • Rare adverse effects: may affect up to 1 in 1,000 people:

  • Excessive thirst

  • Malaise or feeling of unhappiness, slowed thinking

  • Stroke

  • Increased muscle tension, speech difficulties, coordination difficulties, reduced sense of taste, sleep pattern disturbances

  • Vision disturbances, discoloration of the eyeball, dilated pupils, light sensitivity, myopia, watery eyes

  • Irregular heartbeat or changes in heart rhythm

  • Sore throat, snoring

  • Blood in vomit, abnormal stools, coated tongue

  • Numb joints, rib pain

  • Glucose in urine, increased urine volume and frequency

  • Vaginal discharge, changes in sexual ability

  • Feeling of cold, cyst

  • Diabetes

  • Sleepwalking

  • Loss of contact with reality and inability to think or judge clearly (psychosis)

  • Abnormal behaviour

  • Serious skin reactions including erythema multiforme (a type of rash) and Stevens-Johnson syndrome (a serious illness with blisters on the skin, mouth, and around the eyes and genitals)

  • Serious allergic reactions including angioedema (swelling of the face, mouth, or throat)

  • Frequency not known:

  • Transient loss of consciousness

Reporting of adverse effects

If you experience any adverse effect, talk to your doctor or pharmacist, even if it is a possible adverse effect not listed in this leaflet. You may also report them directly through the national reporting system detailed in Appendix V. By reporting adverse effects, you can help provide more information on the safety of this medicine.

5. Storage of CHAMPIX

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date stated on the blister pack or carton after EXP. The expiry date refers to the last day of the month indicated.

Blister packs: Store below 30°C.

Bottle: This medicine does not require any special storage conditions.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines and packaging that you no longer need. This will help protect the environment.

6. Contents of the pack and other information

Composition of CHAMPIX

  • The active substance is varenicline.
  • Each 0.5 mg film-coated tablet contains 0.5 mg of varenicline (as tartrate).
  • Each 1 mg film-coated tablet contains 1 mg of varenicline (as tartrate).
  • The other components are:

Core of the tablet - CHAMPIX 0.5 mg and 1 mg film-coated tablets

Microcrystalline cellulose

Anhydrous calcium hydrogen phosphate

Sodium croscarmellose (see section 2 "CHAMPIX contains sodium")

Anhydrous colloidal silica

Magnesium stearate

Film coating - CHAMPIX 0.5 mg film-coated tablets

Hypromellose

Titanium dioxide (E171)

Macrogol 400

Triacetin

Film-coating of the tablet - CHAMPIX 1 mg film-coated tablets

Hypromellose

Titanium dioxide (E171)

Macrogol 400

Indigo carmine aluminium lake (E132)

Triacetin

Appearance of the product and contents of the pack

  • CHAMPIX 0.5 mg film-coated tablets are modified capsule-shaped, film-coated, white tablets marked with “Pfizer” and “CHX 0.5”

  • CHAMPIX 1 mg film-coated tablets are modified capsule-shaped, film-coated, light blue tablets marked with “Pfizer” and “CHX 1.0”

CHAMPIX is available in the following pack presentations:

  • Starter pack containing 2 blisters; 1 transparent blister with 11 CHAMPIX 0.5 mg film-coated tablets and 1 transparent blister with 14 CHAMPIX 1 mg film-coated tablets, in a cardboard box.
  • Starter pack containing 2 blisters; 1 transparent blister with 11 CHAMPIX 0.5 mg film-coated tablets and 14 CHAMPIX 1 mg film-coated tablets and 1 transparent blister with 28 or 2 transparent blisters with 14 CHAMPIX 1 mg film-coated tablets, in a cardboard box.
  • Starter pack in an outer carton containing 1 pack with 1 transparent blister with 11 CHAMPIX 0.5 mg film-coated tablets and 14 CHAMPIX 1 mg film-coated tablets and 1 transparent blister with 28 or 2 transparent blisters with 14 CHAMPIX 1 mg film-coated tablets in a cardboard box, and 2 packs containing 2 transparent blisters with 28 or 4 transparent blisters with 14 CHAMPIX 1 mg film-coated tablets in a cardboard box.
  • Follow-up (maintenance) packs containing 2 or 4 transparent blisters with 14 or 2 transparent blisters with 28 CHAMPIX 1 mg film-coated tablets, in a cardboard box.
  • Follow-up (maintenance) packs containing 2 or 4 transparent blisters with 14 or 2 transparent blisters with 28 CHAMPIX 0.5 mg film-coated tablets, in a cardboard box.
  • Starter pack containing 2 blisters; 1 transparent blister with 11 CHAMPIX 0.5 mg film-coated tablets and 1 transparent blister with 14 CHAMPIX 1 mg film-coated tablets, in a box.
  • Follow-up (maintenance) packs containing 2, 4, 8, or 10 transparent blisters with 14 CHAMPIX 1 mg film-coated tablets, in a box.
  • White HDPE bottle sealed with a child-resistant screw cap, in a box, containing 56 CHAMPIX 1 mg film-coated tablets.
  • White HDPE bottle sealed with a child-resistant screw cap, in a box, containing 56 CHAMPIX 0.5 mg film-coated tablets.

Only certain pack sizes may be commercially available.

Marketing Authorization Holder

Pfizer Europe MA EEIG
Boulevard de la Plaine 17
1050 Brussels
Belgium

Manufacturer

Pfizer Manufacturing Deutschland GmbH
Mooswaldallee 1
79108 Freiburg im Breisgau
Germany

or

Pfizer Italia S.r.l.
Località Marino del Tronto, 63100
Ascoli Piceno (AP)
Italy

For more information about this medicinal product, please contact the local representative of the Marketing Authorization Holder:

Belgium/Belgium/Belgium

Pfizer S.A./N.V.

Tel/Tel: + 32 (0)2 554 62 11

Lithuania

Pfizer Luxembourg SARL filialas Lietuvoje

Tel. +370 5 2514000

Text in Cyrillic characters on a white background stating Bulgaria, Pfizer Luxembourg SARL, Bulgaria branch, and a telephone number

Luxembourg/Luxembourg

Pfizer S.A.

Tél/Tel: + 32 (0)2 554 62 11

Czech Republic

Pfizer, spol. s r.o.

Tel: + 420 283 004 111

Hungary

Pfizer Kft.

Tel.: +36 1 488 37 00

Denmark

Pfizer ApS

Tlf.: + 45 44 20 11 00

Malta

Vivian Corporation Ltd.

Tel: +356 21344610

Germany

Pfizer Pharma GmbH

Tel: +49 (0)30 550055-51000

Netherlands

Pfizer bv

Tel: +31 (0)10 406 43 01

Estonia

Pfizer Luxembourg SARL Eesti filiaal

Tel: +372 666 7500

Norway

Pfizer AS

Tlf: +47 67 52 61 00

Greece

PFIZER ΕΛΛΑΣ Α.Ε.,

Tel.: +30 210 67 85 800

Austria

Pfizer Corporation Austria Ges.m.b.H.

Tel.: +43 (0)1 521 15-0

Spain

Pfizer, S.L.

Tel: + 34 91 490 99 00

Poland

Pfizer Polska Sp. z o.o.

Tel.: + 48 22 335 61 00

France

Pfizer

Tél: + 33 (0)1 58 07 34 40

Portugal

Laboratórios Pfizer, Lda.

Tel: +351 21 423 5500

Croatia

Pfizer Croatia d.o.o.

Tel: + 385 1 3908 777

Romania

Pfizer România S.R.L.

Tel: +40 (0)21 207 28 00

Ireland

Pfizer Healthcare Ireland Unlimited Company

Tel: 1800 633 363 (toll free)

+44 (0) 1304 616161

Slovenia

Pfizer Luxembourg SARL, Pfizer, podružnica za

svetovanje s podrocja farmacevtske dejavnosti,

Ljubljana

Tel: + 386 (0) 1 52 11 400

Iceland

Icepharma hf.

Simi: +354 540 8000

Slovakia

Pfizer Luxembourg SARL, organizacná zložka

Tel: +421-2-3355 5500

Italy

Pfizer S.r.l.

Tel: +39 06 33 18 21

Finland

Pfizer Oy

Puh/Tel: + 358 (0)9 43 00 40

Cyprus

PFIZER ΕΛΛΑΣ Α.Ε. (CYPRUS BRANCH),

Tel: +357 22 817690

Sweden

Pfizer AB

Tel: + 46 (0)8 550 520 00

Latvia

Pfizer Luxembourg SARL filiale Latvija

Tel: + 371 670 35 775

Date of the most recent review of this leaflet: <{MM/YYYY}>

Other sources of information

Detailed information on this medicinal product is available on the European Medicines Agency website: https://www.ema.europa.eu/.